BeStock  
Stocks › Biotechnology › VOR

Vor Biopharma VOR

US equityMarket cap rank #3050Biotechnology
$19.19 +$0.67 (+3.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.20 +0.05%
Open$18.14
Prev close$18.52
Day range$17.99 – $19.93
Volume1.56M
Market cap$1.18B
P/E (TTM)0.1
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$58.44M-107.9% YoY
Net profit-$86.73M+89.3% YoY
Diluted EPS-$1.45+98.8% YoY
Free cash flow-$32.77M+39.2% YoY
Operating cash flow-$32.75M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-30.7MDec '24$-32.5MMar '25$-1.6BJun '25$-812.7MSep '25$1.7BDec '25$-219.6MMar '26$-62.8MJun '26$-86.7MSep '26

Diluted EPS by quarter

-8.78Dec '24-5.21Mar '25-251.24Jun '25-121.63Sep '2544.50Dec '25-5.11Mar '26-1.16Jun '26-1.45Sep '26

Free cash flow by quarter

$-24.1MDec '24$-31.3MMar '25$-35.3MJun '25$-53.9MSep '25$-23.1MDec '25$-38.3MMar '26$-25.5MJun '26$-32.8MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on assets402.6%
Current ratio13.50
Liabilities / assets127.6%
Cash & investments$481.55M
Total debt$2.44M
Net cash (debt)$479.11M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $58.44M $47.85M $35.16M $371.64M $35.96M
Selling and Admin Expenses $23.91M $21.93M $17.57M $50.11M $16.77M
-General & Admin Expense $23.91M $21.93M $17.57M $50.11M $16.77M
Research & Development $34.53M $25.92M $17.60M $321.53M $19.19M
Operating Profit -$58.44M -$47.85M -$35.16M -$371.64M -$35.96M
Net Non-Operating Interest Income (Expense) $4.61M $4.34M $3.94M $5.87M $2.80M
Non-Operating Interest Income $4.61M $4.34M $3.94M $5.87M $2.80M
Other Income (Expense) -$32.89M -$19.30M -$188.36M -$330.21M $1.76B
Gain on Sale of Security -$32.89M -$19.30M -$188.36M -$334.36M $1.76B
Pretax Profit -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Net Profit -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Profit from Continuing Operations -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Net Income to Parent Company -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Net Income to Common Stockholders -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Basic EPS -$1.45 -$1.16 -$5.11 -$70.50 $44.50
Diluted EPS -$1.45 -$1.16 -$5.11 -$70.50 $44.50
Other Non-Operating Income (Expenses) – – – $4.15M $2,000.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $496.31M $481.05M $506.75M $464.13M $464.13M
Total Current Assets $490.52M $475.11M $500.78M $458.11M $458.11M
Cash and Cash Equivalents & Short-Term Investments $481.55M $466.13M $491.53M $455.21M $455.21M
-Cash and Cash Equivalents $78.98M $107.86M $169.87M $396.49M $396.49M
-Short Term Investments $402.57M $358.27M $321.65M $58.72M $58.72M
Prepaid Assets $4.97M $5.88M $6.39M $1.15M $1.15M
Other Current Assets $4.01M $3.10M $2.86M $1.75M $1.75M
Total Non-Current Assets $5.79M $5.95M $5.97M $6.02M $6.02M
Net PPE $3.23M $3.37M $3.39M $3.47M $3.47M
-Gross PPE $3.36M $3.46M $3.45M $3.49M $3.49M
-Accumulated Depreciation -$128,000.00 -$90,000.00 -$53,000.00 -$25,000.00 -$25,000.00
Other Non-Current Assets $2.56M $2.58M $2.58M $2.55M $2.55M
Total Liabilities $633.49M $681.25M $657.17M $628.44M $628.44M
Total Current Liabilities $36.34M $24.81M $16.08M $25.17M $25.17M
Payables $5.61M $4.00M $1.04M $5.13M $5.13M
-Accounts Payable $5.61M $4.00M $1.04M $5.13M $5.13M
Current Accrued Expenses $23.58M $15.76M $11.80M $16.14M $16.14M
Short-Term Debt and Capital Lease Obligation $370,000.00 $335,000.00 $307,000.00 $280,000.00 $280,000.00
-Current Capital Lease Obligation $370,000.00 $335,000.00 $307,000.00 $280,000.00 $280,000.00
Other Current Liabilities $476,000.00 – $698,000.00 $554,000.00 $554,000.00
Total Non-Current Liabilities $597.14M $656.44M $641.09M $603.27M $603.27M
Long Term Debt and Capital Lease Obligation $2.44M $2.54M $2.63M $2.72M $2.72M
-Long Term Capital Lease Obligation $2.44M $2.54M $2.63M $2.72M $2.72M
Derivative Product Liabilities $594.70M $653.89M $638.46M $600.55M $600.55M
Total Equity -$137.17M -$200.20M -$150.42M -$164.31M -$164.31M
Stockholders' Equity -$137.17M -$200.20M -$150.42M -$164.31M -$164.31M
Capital Stock $20,000.00 $19,000.00 $19,000.00 $18,000.00 $18,000.00
-Common Stock $20,000.00 $19,000.00 $19,000.00 $18,000.00 $18,000.00
-Preferred Stock $0.00 $0.00 – $0.00 $0.00
Additional Paid-In Capital $1.39B $1.24B $1.22B $988.60M $988.60M
Retained Earnings -$1.52B -$1.44B -$1.37B -$1.15B -$1.15B
Gains/Losses Not Affecting Retained Earnings -$1.85M -$922,000.00 -$706,000.00 $41,000.00 $41,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$32.75M -$25.38M -$38.25M -$142.71M -$22.80M
Net cash flow from continuing operations -$32.75M -$25.38M -$38.25M -$142.71M -$22.80M
Net Income from Continuing Operations -$86.73M -$62.81M -$219.59M -$695.98M $1.72B
Gain/Loss from Continuing Operations $32.89M – – $3.30M -$2.09B
Depreciation & Depletion & Amortization $39,000.00 $36,000.00 $28,000.00 $2.89M $23,000.00
Other Non-Cash Items -$1.27M -$188.25M $188.47M $518.03M $334.50M
Change in Working Capital $11.46M $9.01M -$15.54M $10.21M $3.16M
-Change in Prepaid Assets $4,000.00 $278,000.00 -$6.36M $1.68M -$873,000.00
-Change in Payables and Accrued Expense $11.51M $8.80M -$9.10M $10.93M $6.21M
-Change in Other Current Assets $23,000.00 -$7,000.00 -$20,000.00 $0.00 -$2.11M
-Change in Other Current Liabilities -$70,000.00 -$62,000.00 -$61,000.00 -$2.41M -$59,000.00
Net cash flow from investing -$44.78M -$36.53M -$263.24M -$48.80M -$48.97M
Net Cash Flow from Continuing Investing Activities -$44.78M -$36.53M -$263.24M -$48.80M -$48.97M
Net PPE Purchase and Sale -$25,000.00 -$120,000.00 -$48,000.00 -$142,000.00 -$314,000.00
Net Investment Purchase and Sale -$44.76M -$36.41M -$263.19M -$48.66M -$48.66M
Financing Cash Flow $48.65M -$106,000.00 $74.87M $503.81M $307.80M
Net Cash Flow from Continuing Financing Activities $48.65M -$106,000.00 $74.87M $503.81M $307.80M
Net Common Stock Issuance $48.40M $0.00 $75.00M $328.21M $307.95M
Proceeds from Stock Option Exercised $254,000.00 $1,000.00 -$2,000.00 $176.93M -$19,000.00
Net Other Financing Charges $0.00 -$107,000.00 -$127,000.00 -$1.33M -$131,000.00
Ending Cash Balance $79.15M $108.02M $170.04M $396.65M $396.65M
Net Change in Cash -$28.88M -$62.02M -$226.61M $312.29M $236.02M
Beginning Cash Balance $108.02M $170.04M $396.65M $84.36M $160.63M
Free Cash Flow -$32.77M -$25.50M -$38.29M -$143.65M -$23.12M

Discussion

No comments yet — be the first to weigh in on VOR.

Sign in to join the discussion.

Scroll to Top